MedTrace Logo

Efficacy of Diazoxide in Type 1 Diabetes

NCT00131755 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2011-07-18

No results posted yet for this study

Summary

The purpose of this study is to find out if Diazoxide can partly retain insulin production in newly diagnosed type 1 diabetes patients.

Conditions

  • Diabetes Mellitus, Type 1

Interventions

DRUG

diazoxide

Sponsors & Collaborators

  • Grill, Valdemar, M.D.

    lead INDIV

Principal Investigators

  • Grill Valdemar, MD PhD · Norwegian University of Science and Technology

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-02-28
Primary Completion
2008-08-31
Completion
2008-08-31

Countries

  • Norway

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00131755 on ClinicalTrials.gov